Related Experiment Video
Updated: Oct 16, 2025

04:16
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
Published on: August 5, 2021
2.5K
Surface modification strategies to improve titanium hemocompatibility: a comprehensive review
Vignesh K Manivasagam1, Roberta M Sabino2, Prem Kantam1
1Department of Mechanical Engineering, Colorado State University Fort Collins CO USA ketul.popat@colostate.edu.
Summary
Surface modifications improve titanium hemocompatibility for medical implants, reducing blood clot risks. This review analyzes techniques to enhance blood-implant interactions and identifies future research directions.
Area of Science:
- Biomaterials Science
- Surface Chemistry
- Medical Device Engineering
Background:
- Titanium alloys are vital biomaterials due to excellent mechanical properties and bio-inertness.
- Hemocompatibility remains a challenge for blood-contacting titanium implants, leading to thrombus formation and inflammation.
- Current anticoagulant therapies pose risks like immune suppression and bleeding complications.
Purpose of the Study:
- To review surface modification techniques for enhancing titanium hemocompatibility.
- To analyze how surface properties influence blood-implant interactions.
- To identify challenges and future research avenues in titanium hemocompatibility.
Main Methods:
- Literature review of surface modification strategies for titanium.
- Analysis of protein adsorption, platelet adhesion, and immune cell interactions on modified surfaces.
- Evaluation of techniques altering surface morphology, roughness, and chemistry.
Main Results:
- Surface modifications effectively reduce thrombus formation and improve hemocompatibility.
- Changes in surface morphology, roughness, and chemistry are key to successful hemocompatibility enhancement.
- Understanding blood-implant surface reactions is crucial for designing safer medical devices.
Conclusions:
- Surface modification is a promising strategy to overcome hemocompatibility issues in titanium implants.
- Further research is needed to optimize modification techniques and address remaining challenges.
- Enhanced hemocompatibility will lead to improved patient outcomes for blood-contacting devices.

